Trump plans to impose a 200% tariff on imported drugs. Pharmaceutical companies are panicking and preparing to face the challenge of restructuring their supply chains.

President Trump once again made tariff threats this week, saying he would soon announce comprehensive and high tariffs on the global pharmaceutical industry, adding more uncertainty to the already heavily stressed pharmaceutical industry. The proposed tariffs are as high as 200%, and although Trump suggested there might be a 12 to 18 month buffer period, industry analysts widely warned that even if the implementation is delayed, this measure will severely impact drug prices and pharmaceutical profit margins in the United States, and could even lead to disruptions in the supply chain and drug shortages.